Litcius/Paper detail

Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case–Control Study

Shuenn‐Wen Kuo, Pei‐Hsing Chen, Tzu‐Pin Lu, Ke-Cheng Chen, Hsien‐Chi Liao, Kuan‐Chuan Tsou, Tung-Ming Tsai, Mong‐Wei Lin, Hsao‐Hsun Hsu, Jin‐Shing Chen

2022Annals of Surgical Oncology14 citationsDOI

Topics & Concepts

MedicineClinical endpointSurgical oncologyInternal medicineLung cancerEpidermal growth factor receptorPrimary tumorSurgeryRetrospective cohort studyTumor progressionOncologyMetastasisCancerRandomized controlled trialLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis
Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case–Control Study | Litcius